Wells Fargo Starts Merck (MRK) at Outperform; Well Positioned Among Peers As Patent Cliff Looms
Tweet Send to a Friend
Wells Fargo initiates coverage on Merck (NYSE: MRK) with an Outperform. Valuation range: $38-$42.
Wells analyst says, "MRK is potentially ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells analyst says, "MRK is potentially ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
